Enanta Pharmaceuticals Short Interest Ratio and Short Volume

Enanta Pharmaceuticals (NASDAQ:ENTA) Short Interest Frequently Asked Questions

What is Enanta Pharmaceuticals' current short interest?

Short interest is the volume of Enanta Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,210,000 shares of ENTA short. 6.29% of Enanta Pharmaceuticals' shares are currently sold short. Learn More on Enanta Pharmaceuticals' current short interest.

What is a good short interest ratio for Enanta Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Enanta Pharmaceuticals currently has a short interest ratio of 6.0. Learn More on Enanta Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Enanta Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Enanta Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Enanta Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.29% of Enanta Pharmaceuticals' floating shares are currently sold short.

Is Enanta Pharmaceuticals' short interest increasing or decreasing?

Enanta Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,210,000 shares, an increase of 9.0% from the previous total of 1,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Enanta Pharmaceuticals' float size?

Enanta Pharmaceuticals currently has issued a total of 20,710,000 shares. Some of Enanta Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enanta Pharmaceuticals currently has a public float of 19,240,000 shares.

How does Enanta Pharmaceuticals' short interest compare to its competitors?

6.29% of Enanta Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Enanta Pharmaceuticals: Bausch Health Companies Inc. (4.19%), Galapagos NV (0.98%), Arrowhead Pharmaceuticals, Inc. (4.03%), Cerevel Therapeutics Holdings, Inc. (5.17%), Ultragenyx Pharmaceutical Inc. (4.76%), Zai Lab Limited (0.00%), Cytokinetics, Incorporated (0.00%), Blueprint Medicines Co. (6.32%), CureVac (14.09%), and Mirati Therapeutics, Inc. (8.19%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.31 billion), Charter Communications, Inc. ($3.24 billion), Lucid Group, Inc. ($2.25 billion), HP Inc. ($2.22 billion), GameStop Corp. ($1.69 billion), Carnival Co. & plc ($1.66 billion), Snap Inc. ($1.64 billion), Wayfair Inc. ($1.63 billion), Rivian Automotive, Inc. ($1.60 billion), and Upstart Holdings, Inc. ($1.53 billion). View all of the most shorted stocks.

What does it mean to sell short Enanta Pharmaceuticals stock?

Short selling ENTA is an investing strategy that aims to generate trading profit from Enanta Pharmaceuticals as its price is falling. Enanta Pharmaceuticals' stock is trading down $2.06 today. To short Enanta Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Enanta Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enanta Pharmaceuticals?

A short squeeze for Enanta Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTA, which in turn drives the price of the stock up even further.

How often is Enanta Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTA, twice per month. The most recent reporting period available is April, 30 2022.